Topical Collection on Nonstatin Drugs

In this topical collection (74 articles)

Page is not a valid page number. Please enter a number between 1 and 4 of 4

1. 

   Nonstatin Drugs (WB Borden, Section Editor)

   HDL Hypothesis: Where Do We Stand Now?

   Sayed M. Tariq, Mandeep S. Sidhu, Peter P. Toth… Article:398

2. 

   Nonstatin Drugs (WB Borden, Section Editor)

   Update in Therapeutic Approaches to Plaque Stabilization

   Stephen J. Nicholls, Yu Kataoka Article:392

3. 

   Nonstatin Drugs (WB Borden, Section Editor)

   Cardiometabolic Impact of Non-Statin Lipid Lowering Therapies

   Parag Goyal, Leon I. Igel, Keith LaScalea… Article:390

4. 

   Nonstatin Drugs (WB Borden, Section Editor)

   Omega-3 Fatty Acids: A Growing Ocean of Choices

   Hassan Fares, Carl J. Lavie, James J. DiNicolantonio… Article:389

5. 

   Nonstatin Drugs (WB Borden, Section Editor)

   Treatment of Cholesterol in the Elderly: Statins and Beyond

   John C. LaRosa Article:385

6. 

   Nonstatin Drugs (WB Borden, Section Editor)

   Novel Therapies for Treating Familial Hypercholesterolemia

   Salman J. Bandeali, Jad Daye, Salim S. Virani Article:382

7. 

   Nonstatin Drugs (WB Borden, Section Editor)

   Potential of Proprotein Convertase Subtilisin/Kexin Type 9 Based Therapeutics

   Evan A. Stein, Gary D. Swergold Article:310

8. 

   Nonstatin Drugs (WB Borden, Section Editor)

   Pharmacologic Interactions of Multidrug Therapy for Dyslipidemia

   Nidhi Mehta, Emil M. deGoma Article:303

9. 

   Nonstatin Drugs (WB Borden, Section Editor)

   Advances in Pharmacologic Therapies for Type 2 Diabetes

   Linde M. Morsink, Mark M. Smits, Michaela Diamant Article:302

10. 

    Nonstatin Drugs (WB Borden, Section Editor)

    Vitamin D, Calcium, and Atherosclerotic Risk: Evidence from Serum Levels and Supplementation Studies

    Pamela L. Lutsey, Erin D. Michos Article:293

11. 

    Nonstatin Drugs (WB Borden, Section Editor)

    Lipid Effects of Psychiatric Medications

    Junzo Watanabe, Yutaro Suzuki, Toshiyuki Someya Article:292

12. 

    Nonstatin Drugs (E. deGoma, Section Editor)

    Chronic Toxic Metal Exposure and Cardiovascular Disease: Mechanisms of Risk and Emerging Role of Chelation Therapy

    Ehimen C. Aneni, Esteban Escolar, Gervasio A. Lamas Article:81

13. Nonstatin Drugs (M. Vrablik, Section Editor)

    Monoclonal Antibodies in the Management of Familial Hypercholesterolemia: Focus on PCSK9 and ANGPTL3 Inhibitors

    Angela Pirillo, Alberico L. Catapano, Giuseppe D. Norata Article:79

    Download PDF (1249KB) View Article

14. Nonstatin Drugs (M. Vrablik, Section Editor)

    Oral Lipid-Lowering Treatments Beyond Statins: Too Old and Outdated or Still Useful?

    Klaus G. Parhofer Article:74

    Download PDF (736KB) View Article

15. 

    Nonstatin Drugs (M. Vrablik, Section Editor)

    Omega n-3 Supplementation: Exploring the Cardiovascular Benefits Beyond Lipoprotein Reduction

    Alberto Zambon, Angela Pirillo, Sabina Zambon… Article:74

16. Nonstatin Drugs (M. Vrablik, Section Editor)

    RNA Silencing in the Management of Dyslipidemias

    Neil C. Henney, Maciej Banach, Peter E. Penson Article:69

    Download PDF (969KB) View Article

17. 

    Nonstatin Drugs (M. Vrablik, Section Editor)

    Therapeutic Apheresis for Management of Lp(a) Hyperlipoproteinemia

    Sergei N. Pokrovsky, Olga I. Afanasieva, Marat V. Ezhov Article:68

18. Nonstatin Drugs (M. Vrablik, Section Editor)

    The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with Dyslipidaemia

    Peter E. Penson, Maciej Banach Article:67

    Download PDF (331KB) View Article

19. 

    Nonstatin Drugs (M. Vrablik, Section Editor)

    Targeting Inflammation to Reduce Residual Cardiovascular Risk

    Oluremi N. Ajala, Brendan M. Everett Article:66

20. 

    Nonstatin Drugs (E. deGoma, Section Editor)

    ApoCIII as a Cardiovascular Risk Factor and Modulation by the Novel Lipid-Lowering Agent Volanesorsen

    Natalia A. Rocha, Cara East, Jun Zhang… Article:62

Page is not a valid page number. Please enter a number between 1 and 4 of 4